-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Implementation of strategic management tools improves wound care clinical trial outcomes
Marina Malikova, Lauren Shifflett & Alik Farber
Review: Clinical Trail Outcomes: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Will thrombopoietin receptor agonists become a treatment option for pediatric chronic immune thrombocytopenia in the future?
Gregory Cheng
Clinical Trail Perspective: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Incidental findings in clinical research: the case of the known unknown
Blair Henry
Editorial: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Physiological intervention studies often fail to adequately control for the placebo effect
News and Views: Clinical Investigation
-
Clinical trials and overactive bladder: lessons learned
Ariana L Smith, Alan J Wein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials and overactive bladder: lessons learned
Ariana L Smith, Alan J Wein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials and overactive bladder: lessons learned
Ariana L Smith, Alan J Wein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials and overactive bladder: lessons learned
Ariana L Smith, Alan J Wein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials and overactive bladder: lessons learned
Ariana L Smith, Alan J Wein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials and overactive bladder: lessons learned
Ariana L Smith, Alan J Wein
Review: Clinical Trail Outcomes: Clinical Investigation